The first engineered cell therapy has come to the fight against solid tumors. Fox Chase Cancer Center has begun using Tecelra ...
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...
The acquisition bolsters Gilead’s sputtering cell therapy business with a medication the company expects to become a ...
In an analysis of therapeutic interventions following the failure of chimeric antigen receptor (CAR) T-cell therapy, Rahul ...
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite ...
Johnson & Johnson, the healthcare and lifestyle giant announced a more than $1 billion dollar investment in next generation ...
With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion ...
Galapagos took a 228 million euro ($269 million) hit last year as it began to close its cell therapy business, but the Belgian biopharma is confident it can stabilize its finances by the end of the ...
Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients a year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results